7.1.3.6	  Guidelines for the treatment of clinical stage I non-seminoma testis,
Summary of evidence,LE
Thromboembolic events occur more frequently in male patients with GCTs receiving chemotherapy   than in young males under chemotherapy for other cancers.,2b
"Retrospective studies have identified multiple risk factors for the development of thromboembolic   events including increasing stage, size of retroperitoneal lymph nodes at different cut-offs, Khorana   score > 3 and indwelling vascular access device (only modifiable risk factor).",2b
